Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Best Stocks to Invest In

Stock investing can be exciting, but it shouldn’t be a rollercoaster ride for investors. If you know how to read company reports, basis spreadsheets, and what financial measures to review, you’re more likely to pick a winning stock. Staying up...

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...

Biopharma to Accelerate Alzheimer Trial Completion

The upcoming catalysts for Axsome Therapeutics and the effects of COVID-19 on its clinical activities are discussed in an H.C. Wainwright & Co. report. In a March 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Axsome Therapeutics Inc. ...

Potential Rerating Ahead for New Gold Producer

Why it is a good time to get into Lundin Gold stock and the company's major move in response to COVID-19 are covered in an Echelon Wealth Partners report. In a March 23 research note, Echelon Wealth Partners analyst Ryan Walker wrote that the big recent pull...

Supporting the Clean Energy Industry Through the COVID-19 Response

A Letter to the Clean Energy Industry Businesses and Employees Without doubt, Zinc8 Energy Solutions Inc. has the best possible partners to continue its path to full commercialization of its unique, patented, low-cost, long-duration energy storage system. On Apr...

Fed Was Caught Off Guard by the Economic Shock. And Gold?

Another week passed, and the number of jobless claims increased further. That was clearly not expected by the Fed, as the recent minutes shows. What does it all mean for the gold market? Unemployment Claims Rose Further Initial jobless claims have become one the most im...

How Investors Can Jump on the ESG Train

Back in August , we introduced our Stockhouse investor audience to a very different, and very profitable, kind of ESG company that’s been a market leader in Environmental Services – Vertex Resource Group Ltd. ( TSX-V.VTX , Forum ). In this exclusive ...

Buzz on the Bullboards: Markets React to Uncertainty Over US Election Outcome

(Screenshots via CNN video.) It has been a tumultuous time for the markets, from abrupt deep dips to relief rallies that saw effects to indexes on both sides of the border. US stock futures have been northing short of volatile in the last few days with the president...
1 2 3 4 5 6 7 8 9 10 ...